A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita

Park Avenue Dermatology, Orange Park

Minnesota Clinical Study Center, Fridley

DermResearch, Inc., Austin

University of Utah, Murray

Stanford University, Palo Alto

Oregon Health and Sciences University, Portland

Yale University, New Haven

Royal London Hospital, London